In 2020 we saw fast startup timelines for clinical trials and adaptations to trial designs to adjust to COVID-19. Regulatory authorities formulated more guidelines around decentralized trials, and while some sponsors capitalized on previous experiences, many used a decentralized model for the first time. If we’ve learned anything this year, it’s that direct-to-patient logistics has become a vital and viable solution for clinical trial sponsors.
Advancing into 2021, it’s all about building more inclusive and patient-focused trials. So how can sponsors better incorporate the patient voice into their trials? How do we see decentralized trial capabilities expanding in the coming months to support this new era?
In this presentation, attendees will learn:
December 10, 2020
11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)